Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Fuji
Daiichi Sankyo
QuintilesIMS
Teva
Chinese Patent Office
Novartis
Boehringer Ingelheim
US Department of Justice
McKinsey

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,160,744

« Back to Dashboard

Summary for Patent: 5,160,744
Title: Verapmil therapy
Abstract:A dosage form is disclosed comprising means for delaying the delivery of drug from the dosage form following the administration of the dosage form to a patient in need of drug therapy.
Inventor(s): Jao; Frank (San Jose, CA), Wong; Patrick S. (Palo Alto, CA), Huynh; Hoa T. (Fremont, CA), McChesney; Kathy (Cupertino, CA), Wat; Pamela K. (Santa Clara, CA)
Assignee: Alza Corporation (Palo Alto, CA)
Application Number:07/722,622
Patent Claim Types:
see list of patent claims
Dosage form; Delivery; Composition; Use;

Drugs Protected by US Patent 5,160,744

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,160,744

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 165000 ➤ Try a Free Trial
Australia 2255092 ➤ Try a Free Trial
Australia 654871 ➤ Try a Free Trial
Canada 2105165 ➤ Try a Free Trial
Germany 69225135 ➤ Try a Free Trial
European Patent Office 0591389 ➤ Try a Free Trial
Spain 2114562 ➤ Try a Free Trial
Finland 110919 ➤ Try a Free Trial
Finland 935844 ➤ Try a Free Trial
Greece 3026674 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Daiichi Sankyo
Chubb
Teva
Cantor Fitzgerald
Accenture
Johnson and Johnson
UBS
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot